Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$233 Sell
25
-902
-97% -$8.39K ﹤0.01% 319
2026
Q1
$9.28K Hold
927
0.01% 156
2025
Q4
$9.37K Hold
927
0.01% 159
2025
Q3
$8.31K Buy
927
+902
+3,608% +$8.69K 0.01% 175
2025
Q2
$259 Hold
25
﹤0.01% 242
2025
Q1
$239 Hold
25
﹤0.01% 242
2024
Q4
$239 Hold
25
﹤0.01% 329
2024
Q3
$265 Hold
25
﹤0.01% 375
2024
Q2
$207 Hold
25
﹤0.01% 377
2024
Q1
$215 Hold
25
﹤0.01% 376
2023
Q4
$206 Buy
+25
New +$206 ﹤0.01% 372

Other funds holding HLN

Fairman Group's HLN Position: Q2 2026 in Review

Fairman Group reduced its Haleon (HLN) stake by 97% in Q2 2026, selling an estimated $8.39K and leaving 25 shares worth $233. The position accounts for ﹤0.01% of the portfolio, ranked #319.

Fairman Group first reported a position in HLN in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.37K in Q4 2025. 344 funds tracked by Wall St. Rank hold HLN as of Q2 2026.

  • Fairman Group held 25 shares of Haleon worth $233 as of Q2 2026.
  • Fairman Group sold 902 Haleon shares in Q2 2026, an estimated $8.39K.
  • Haleon made up ﹤0.01% of Fairman Group's portfolio in Q2 2026, its #319 holding.
  • Fairman Group first reported a position in Haleon in Q4 2023 and has held it in 11 quarters since.
  • Fairman Group's Haleon position peaked at $9.37K in Q4 2025.
  • 344 funds tracked by Wall St. Rank held Haleon as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.